Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders

Details for Australian Patent Application No. 2005262496 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Parker, Michael N.; Maryanoff, Bruce E.; McComsey, David F.; Reitz, Allen B.

Agent Shelston IP

Pub. Number AU-B-2005262496

PCT Pub. Number WO2006/007435

Priority 60/580,178 16.06.04 US

Filing date 16 June 2005

Wipo publication date 19 January 2006

Acceptance publication date 20 October 2011

International Classifications

C07D 321/08 (2006.01) Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups

A61K 31/353 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

C07D 311/58 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 317/58 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 319/20 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/007435 Priority application(s): WO2006/007435

25 January 2007 Amendment Made

  The nature of the amendment is:Amend co-inventor name from Reitz, Alen B and Reitz, Allen B.

20 October 2011 Application Accepted

  Published as AU-B-2005262496

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005262497-Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders

2005262493-Nucleic acid molecules encoding wrinkled1-like polypeptides and methods of use in plants